Sr One Capital Management »

Oculis Holding shares owned by Sr One Capital Management

Quarter-by-quarter ownership of Oculis Holding (OCS) shares owned by Sr One Capital Management from 13F filings

Historical chart of Sr One Capital Management investment in Oculis Holding

Tip: Access up to 7 years of quarterly data

All positions including Oculis Holding held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oculis Holding by Sr One Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.7M 323k 17.58
2025-06-30 $6.3M 323k 19.41
2025-03-31 $6.1M 323k 19.03

More positions owned by Sr One Capital Management

Arcellx Common Stock (ACLX)
CRISPR Therapeutics Common Shares (CRSP)
Zenas BioPharma Common Stock (ZBIO)
Mineralys Therapeutics Common Stock (MLYS)
ORIC Pharmaceuticals Common Stock (ORIC)
Design Therapeutics Common Stock (DSGN)
ARS Pharmaceuticals Common Stock (SPRY)
Oruka Therapeutics Common Stock (ORKA)
Alumis Common Stock (ALMS)
Nkarta Common Stock (NKTX)
Oculis Holding Ordinary Shares (OCS)
enGene Holdings Common Shares (ENGN)

View all positions for Sr One Capital Management

Top funds holding Oculis Holding

EQT Fund Management S.a r.l.
Pivotal bioVenture Partners Investment Advisor
Standard Life Aberdeen
Nan Fung Group Holdings
Sr One Capital Management
Syquant Capital Sas
Alyeska Investment Group
Compagnie Lombard, Odier SCA
Longwood Capital Partners
Woodline Partners
UBS Group
Geode Capital Management
Northern Trust
State Street Corporation
Aventura Private Wealth

View all funds holding Oculis Holding